Newsroom

RESTON, Va.--(BUSINESS WIRE)--The Brick Industry Association (BIA) has opened entries for the 2026 Brick in Architecture Awards, the leading international design competition featuring fired-clay brick. Entries are due by September 25 at 11:59 p.m. EDT. Project entries in nine categories will compete for a Best in Class, Gold, Silver or Bronze award and an overall Craftsmanship Award. The winners will be judged by peers in October. Winning projects and teams will be honored live at the Brick Exc...

CUPERTINO, Calif.--(BUSINESS WIRE)--Apple® today previewed a new suite of powerful, intuitive, and easy-to-use features designed to allow parents to more easily manage the content their children can see, who they can communicate with, and when they have access to apps. With software updates this fall, parents will be able to access new child safety features, including a simpler setup experience with a recommended set of essential apps, Ask to Browse, Time Allowances, and a redesigned Screen Tim...

CUPERTINO, Calif.--(BUSINESS WIRE)--Apple® today introduced the next generation of Apple Intelligence™, powered by a bold new architecture that integrates the latest Apple Foundation Models deep into Apple’s platforms and is uniquely designed to protect users’ privacy. This makes the apps and experiences users rely on every day across iPhone®, iPad®, Mac®, Apple Watch®, AirPods®, and Apple Vision Pro® more personal and helpful than ever. Apps become smarter and more useful with powerful editing...

CUPERTINO, Calif.--(BUSINESS WIRE)--Apple® today introduced Siri® AI, an entirely new version of Siri, powered by Apple Intelligence™. A profoundly more capable and conversational assistant with personal context understanding, broad world knowledge, and onscreen awareness, Siri AI can help users find what they need in the moment, from answering questions from the web on virtually any topic, to surfacing relevant information from a user’s personal messages, emails, photos, and more. Siri AI also...

CUPERTINO, Calif.--(BUSINESS WIRE)--Today, during the Worldwide Developers Conference, Apple® previewed its upcoming software releases that will deliver the next generation of Apple Intelligence™ and introduce Siri® AI, an entirely new version of Siri that is profoundly more intelligent, knowledgeable, and capable. The releases also bring powerful and intuitive new features to help parents create safe digital experiences for kids, as well as improvements that further elevate the software design...

斯洛文尼亚卢布尔雅那--(BUSINESS WIRE)--(美国商业资讯)-- Cosylab今日宣布正式商业化推出PlanOne™，这是一款用于粒子治疗的治疗计划系统，将物理学计算精准、基于放射生物学信息的规划以及统一的临床工作流集成于单一环境之中。PlanOne™已获得美国食品药品监督管理局(FDA)的510(k)认证。 Cosylab首席执行官Mark Pleško表示：“PlanOne™的诞生源于倾听。多年来，我们深耕放射肿瘤学控制系统领域，这使我们与全球一些顶尖医疗机构的医学物理师和临床团队保持着直接且持续的沟通。我们的合作伙伴明确指出了粒子治疗中最关键的三点：值得信赖的物理精度、在计划审批节点上的临床信心，以及一个能够随AI和自适应工作流共同发展的平台。我们围绕这三个核心优先事项设计了PlanOne™，并将继续与帮助塑造该系统的临床界共同对其进行迭代开发。” 物理学计算精准、基于放射生物学信息的规划 PlanOne™建立在用于粒子治疗的GPU加速蒙特卡洛(Monte Carlo)剂量引擎之上，该引擎为精准的线性能量转移(LET)计算和可变相对生物学效应(RBE)建模*提供了...

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best will be exhibiting during the Florida Association of Insurance Agents’ (FAIA) 122nd Convention and Education Symposium, which is scheduled to take place June 17–19, 2026, at the Gaylord Palms Resort & Convention Center in Orlando, FL.Visitors to the AM Best booth, which is No. 509, can learn about the rating agency, its role in the insurance industry and the resources it offers to insurance professionals, including Best’s Credit Ratings, Best’s Perform...

印度来楚尔和西班牙巴塞罗那--(BUSINESS WIRE)--(美国商业资讯)-- Shilpa Medicare Limited (BSE/NSE: SHILPAMED)子公司Shilpa Biocare Pvt Ltd已与专注于中枢神经系统(CNS)治疗的生物技术公司Gate2Brain, S.L.达成战略股权合作。Shilpa将成为Gate2Brain核心项目G2B-002的战略股东以及化学制造与控制(CMC)、生产和监管合作伙伴。G2B-002是Gate2Brain针对致命性儿童脑癌——弥漫性内桥脑胶质瘤(DIPG)和儿童胶质母细胞瘤(pGBM)的开发的核心管线，这两项适应症均已获得美国食品药品监督管理局(FDA)和欧洲药品管理局(EMA)的孤儿药资格认定。G2B-002利用Gate2Brain专有的MiniAp4多肽穿梭载体，将SN-38递送透过血脑屏障，在临床前研究中展现出高达100倍的脑部药物转运效率提升。首次人体临床试验预计将于2028财年启动。 G2B-002瞄准了高增长的肿瘤学市场——胶质母细胞瘤市场规模预计到2035年将达到64.8亿美元（年复合增长率7.97%...

RAICHUR, India & BARCELONA, Spanje--(BUSINESS WIRE)--Shilpa Biocare Pvt Ltd, een dochteronderneming van Shilpa Medicare Limited (BSE/NSE: SHILPAMED), is een strategisch aandelenpartnerschap aangegaan met Gate2Brain, S.L., een biotechnologiebedrijf dat zich richt op geneesmiddelen voor het centrale zenuwstelsel. Shilpa wordt strategisch aandeelhouder en partner op het gebied van CMC, productie en regelgeving voor G2B-002. Dit is het belangrijkste programma van Gate2Brain gericht op DIPG en pGBM,...

RAICHUR, Indien & BARCELONA, Spanien--(BUSINESS WIRE)--Shilpa Biocare Pvt Ltd, eine Tochtergesellschaft von Shilpa Medicare Limited (BSE/NSE: SHILPAMED), ist eine strategische Kapitalpartnerschaft mit Gate2Brain, S.L., einem auf Therapeutika für das zentrale Nervensystem spezialisierten Biotechnologieunternehmen, eingegangen. Shilpa wird strategischer Anteilseigner sowie Partner für CMC, Herstellung und Zulassungsangelegenheiten für G2B-002 – das Leitprogramm von Gate2Brain zur Behandlung der t...